EU Commission Targets Teva Over Alleged Copaxone Antitrust Breach

Teva Prepared To Use ‘All The Legal And Procedural Rights’ Available

 
• By Dean Rudge
  
EU Brussels
The EC had conducted inspections of Teva in 2019 • Source: Shutterstock
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Legal & IP

More from Generics Bulletin